AD is characterized by progressive neuropathological processes including cognitive function impairment and memory loss principally caused by increased accumulation of amyloid-β (Aβ) plaques, and hyperphosphorylated tau protein (Nakamura et al., 2018; Silva et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.